Abbott To Buy Starlims In $123M Cash Deal

Law360, New York (December 15, 2009, 5:29 PM EST) -- Abbott Laboratories Inc. will acquire information systems producer Starlims Technologies Ltd. for about $123 million in cash, in a deal the drugmaker says will strongly position it in the emerging field of health care informatics.

Under the deal, announced by the companies Monday, Abbott will acquire all outstanding equity in Starlims for $14 per share.

Abbott said the acquisition would help improve its position in the growing market for technologies that organize and help to interpret patient medical data, known as health care informatics, which Abbott...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.